- Home
- UMBF vs AXSM Comparison
UMBF vs AXSM Comparison
Compare UMBF & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UMBF | AXSM |
|---|---|---|
| Founded | 1913 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 10.4B |
| IPO Year | 2007 | 2015 |
Fundamental Metrics
Financial Performance| Metric | UMBF | AXSM |
|---|---|---|
| Price | $140.33 | $202.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 17 |
| Target Price | $138.90 | ★ $211.12 |
| AVG Volume (30 Days) | 443.8K | ★ 619.1K |
| Earning Date | 04-28-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.39% | N/A |
| EPS Growth | 3.34 | ★ 38.56 |
| EPS | ★ 6.90 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $18.07 | $57.24 |
| Revenue Next Year | $6.85 | $55.88 |
| P/E Ratio | $20.53 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $103.38 | $112.90 |
| 52 Week High | $153.32 | $260.19 |
Technical Indicators
Market Signals| Indicator | UMBF | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 38.67 | 36.46 |
| Support Level | $137.23 | $179.00 |
| Resistance Level | $148.40 | $222.93 |
| Average True Range (ATR) | 2.71 | 6.20 |
| MACD | -0.91 | -0.47 |
| Stochastic Oscillator | 5.98 | 19.55 |
Price Performance
Historical ComparisonAbout UMBF UMB Financial Corporation
UMB Financial Corp, or UMBF, is a financial services holding company offering a suite of banking services and asset servicing to its customers in the United States and around the world. Its client base includes commercial, institutional, and personal customers. Along with its subsidiaries, the company operates in the following business segments: Commercial Banking, Institutional Banking, and Personal Banking. A majority of its revenue is generated from the Commercial Banking segment, which serves the commercial banking and treasury management needs of small to middle-market businesses through various products and services such as commercial loans, commercial real estate financing, commercial credit cards, letters of credit, loan syndication services, consultative services, and others.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.